✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceGBM-004
Loading study workspace…
3D Tumour Intelligence

GBM-004

ImagingRESEARCH MODE

Glioblastoma Penetration Study

AssetOGC-NS-321CancerGlioblastomaSubtypeIDH-wildtypeModelPatient-derived OrganoidLead ScientistDr. M. Rossi
Review DiscussionAsk OSIEL About This Study

Study Summary

Scientific context and protocol

CNS penetration may improve tumour core exposure.

Linked AssetOGC-NS-321
Cancer / SubtypeGlioblastoma · IDH-wildtype
ModelPatient-derived Organoid
InvestigatorsDr. Sarah Mokoena · Dr. J. Patel
ProtocolOG-PROT-ORG-012
Start Date2026-09-21
Current StageImaging
Data ModeRESEARCH

Key Result

Day 7 response · illustrative scientific data

DRUG B

Analysis Pending

Study has not reached final response analysis.

ViabilityPending
Tumour sizePending
ConfidencePending

Treatment Overview

Control and two intervention groups

Control0 · 3 replicates
Drug A0.1 µM · 3 replicates
Drug B0.8 µM · 3 replicates

Timepoints

Longitudinal image and response capture

Day 0Day 3Day 7

Current analytical timepoint: Not yet analysed.

Study Timeline

Completed, current, and upcoming workflow

Setup
Samples
Treatment
Imaging
Segmentation & QC
Response Analysis
Scientific Review
Approved Result

Current Alerts

Research review required

Imaging review pendingNeeds Review
Needs Review QC status requires confirmationNeeds Review

Study Context

Current scientific record

StageImaging
QCNeeds Review
ProtocolOG-PROT-ORG-012
Images92
Last Updated2026-10-01

Current Attention

Research review queue

Imaging review pendingNeeds Review QC status requires confirmation
Research data · human review required.